Blind guy finds a surprise in his candy bowl #shorts If you have any interest at all in what you just saw and you’d like to ...

I’d avoid them if I could…but I can’t see the damn things. #shorts If you have any interest at all in what you just saw and ...

Significantly lower AMD risk compared with other agents in cohort study ...

Healthy Vision Month in May is a great time for Texans to focus on protecting their vision health and preventing eye disease. To keep eyes healthy, schedule regular eye exams to check for common ...

PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...

Many common conditions linked to aging develop without symptoms for years. Learn which five pose the biggest risks and the ...

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...

PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...

DURAVYU has established safety and efficacy data from both Phase 1 and 2 trials in wet AMD and DME that demonstrate stability in vision and anatomical control with a single dose of DURAVYU. No ...

Near-infrared light is invisible to humans. And yet, under the right conditions, the human eye can perceive it. Researchers ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...